Niowave and Ratio Therapeutics have signed a supply agreement for Actinium-225, strengthening Ratio’s access to a ...
Hillhurst Bio has dosed the first subject in its Phase 2a clinical trial evaluating HBI-002 for the treatment of Parkins...
CARsgen Therapeutics has presented new clinical data for two allogeneic CAR-T cell therapy candidates, CT0596 and CT1190...
Rznomics has presented interim Phase 1/2a clinical data for RZ-001, its RNA editing-based anticancer gene therapy for re...
Inflammatory bowel disease is becoming a growing focus within immunology innovation across Asia-Pacific, as the region s...
MaaT Pharma has presented final Phase 3 data from the ARES pivotal trial evaluating MaaT013 in acute graft-versus-host d...
Pfizer has received US FDA approval for an expanded indication of Hympavzi for hemophilia A or B, broadening its use to ...
Eli Lilly has reported detailed Phase III results from three ACHIEVE trials evaluating Foundayo, or orforglipron, an ora...
VERTANICAL has received marketing authorisation in Germany for Exilby, or VER-01, for the treatment of chronic low back ...
The Department of Orthopaedic Surgery at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medi...
Researchers from the National Institute of Education, Nanyang Technological University, Singapore (NIE NTU, Singapore)...
Johnson & Johnson has received US FDA approval for a supplemental Biologics License Application to include evidence ...
An international research team led by the A*STAR Genome Institute of Singapore (A*STAR GIS) has developed HERRO, an arti...
This year’s meeting highlighted a dramatic shift in the geography of cancer drug development. Long viewed as &ldqu...
A study led by Dr Jason Pitt, Principal Investigator at the Cancer Science Institute of Singapore (CSI Si...
As Asia’s biologics ecosystem continues to scale rapidly across monoclonal antibodies, biosimilars, and ad...
The Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) has announced a research partnershi...
Scientists from A*STAR Infectious Diseases Labs (A*STAR IDL), Nanyang Technological University, Singapore’s Lee Ko...
When the liver fails, toxins – such as ammonia – that should be filtered from the blood build up and reach t...
Japan-based iPark Institute has signed a Memorandum of Understanding (MoU) with Taiwan’s Industrial Technology Res...
Researchers at King Abdullah University of Science and Technology (KAUST), Saudi Arabia, have developed a new method to ...
Taiwan-based China Medical University Hospital (CMUH), in collaboration with Ever Supreme International Biotechnology an...
NTU Singapore and Nanofilm Technologies International (NTI Nanofilm) have officially opened the NTI-...
Mirxes, the only publicly-listed molecular cancer early detection company in Asia Pacific, has developed an AI assistant...
Israel-based Galmed Pharmaceuticals, a clinical-stage biopharmaceutical company for liver disease and GI oncological the...
